LifeScan said yesterday that it entered into an agreement with Willis Towers Watson to expand the commercialization of its OneTouch Reveal Plus digital diabetes therapy system. The companies hope the collaboration will see LifeScan and Willis Towers Watson combine to support self-insured employers in helping their employees and dependents manage diabetes. The OneTouch Reveal Plus […]
LifeScan Inc.
HeartFlow taps ex-Beaver-Visitec CEO Mead as chief exec | Personnel Moves – May 28, 2019
HeartFlow said today that it named former Beaver-Visitec prez & CEO Dana Mead, Jr., as its new president and CEO, replacing current prez & CEO Dr. John Stevens, who will continue to serve on the board as chair. Prior to joining Beaver-Visitec, Mead served as a strategic advisor and partner in Kleiner Perkins Caufield & […]
Medtronic taps Lennon as CIO | Personnel Moves – April 9, 2018
Medtronic (NYSE:MDT) said that it named Sean Lennon as its new chief information officer, set to take effect April 29. The Fridley, Minn.-based medtech giant said that Lennon will take over for Mike Hedges, who is retiring from the position after 19 years with Medtronic, including 10 as CIO. Prior to joining Medtronic, Lennon served as […]
LifeScan releases latest version of diabetes management app
LifeScan said today that it released the latest version of its OneTouch Reveal mobile app. The digital tool is designed to help people with diabetes track their blood sugar levels using their mobile devices and share data with healthcare teams and caregivers. The newest version of LifeScan’s app includes notifications that automatically warn users of recurring […]
Johnson & Johnson OKs $2B LifeScan sale to Platinum Equity
Johnson & Johnson (NYSE:JNJ) said today that it accepted a binding offer of more than $2 billion from private equity shop Platinum Equity for its LifeScan blood glucose monitoring business as it moves toward the exit in the diabetes market. The New Brunswick, N.J.-based healthcare conglomerate early last year announced a strategic review of its LifeScan, […]
Johnson & Johnson moves closer to exiting the diabetes business with $2.1B LifeScan sale
Johnson & Johnson (NYSE:JNJ) took another step toward the exit door for the diabetes business, agreeing to a $2,1 billion offer from private equity shop Platinum Equity for its LifeScan blood glucose monitoring unit. The New Brunswick, N.J.-based healthcare conglomerate early last year announced a strategic review of its LifeScan, Animas and Calibra Medical diabetes businesses and later […]
J&J’s LifeScan touts studies of OneTouch blood glucose monitoring system
Two recently-published studies of LifeScan‘s OneTouch Verio Flex blood glucose monitoring system showed that the technology is accurate, reliable and linked with improvements in glycemic control, the Johnson & Johnson (NYSE:JNJ) business touted today. The release comes just days after the healthcare giant revealed that it plans to shut down its Animas insulin pump business and review its LifeScan division. […]
ADA 2017 Roundup: J&J inks dev deal with Qualcomm, launches next-gen OneTouch Reveal app
Johnson & Johnson (NYSE:JNJ) is continuing to develop its diabetes offerings, with its LifeScan business partnering with Qualcomm Life to improve its OneTouch Verio Flex blood glucose meters and launching a next-gen version of its OneTouch Reveal mobile app. The company will be partnering with the Qualcomm subsidiary to streamline wireless data capture from LifeScan’s […]
J&J’s LifeScan wins FDA clearance for WellDoc integration of blood glucose data
Johnson & Johnson (NYSE:JNJ) subsidiary LifeScan said today it won FDA clearance for wireless integration of its OneTouch Verio Flex blood glucose monitoring system with WellDoc‘s FDA-approved BlueStar diabetes management system. The OneTouch Verio Flex system is now cleared to automatically wirelessly transmit blood glucose monitoring data to WellDoc’s BlueStar system, which in turn provides patients with real-time […]
Diabetes: J&J’s LifeScan inks collab deal with WellDoc
Johnson & Johnson (NYSE:JNJ) subsidiary LifeScan said today it inked a strategic collaboration deal with WellDoc Corporation and joined in a Series B round of financing for the company, with goals of advancing mobile solutions for Type 2 diabetes patients. Through the collaborative deal, the companies said they will seek to integrate LifeScan’s OneTouch Verio Flex […]
Decision Dx wins test strip patent challenge to J&J’s LifeScan
A federal appeals court yesterday upheld a U.S. Patent & Trademark Office decision that a blood glucose testing patent owned by JNJ subisidary LifeScan is invalid. The U.S. Court of Appeals for the Federal Circuit’s per curiam decision, issued without comment, was a win for Decision Diagnostics (OTC:DECN) subsidiary PharmaTech Solutions and its GenStrip 50 test strip. […]
